Los puntos clave no están disponibles para este artículo en este momento.
Editorials15 February 1989Disease Associated with Clostridium difficile InfectionDale N. Gerding, MDDale N. Gerding, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-110-4-255 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptNot only is it difficult to diagnose gastrointestinal illness caused byClostridium difficileorganisms, it is even difficult to reconcile all the terms that have historically evolved to describe the illness, including pseudomembranous enterocolitis, pseudomembranous colitis, antibiotic-associated colitis, clindamycin-associated colitis, antibiotic-associated pseudomembranous colitis, antibiotic-associated diarrhea,C. difficilecolitis,C. difficilediarrhea, andC. difficile—associated disease (the latter term reflects the spectrum of disease from self-limited diarrhea to colitis and life-threatening toxic megacolon). The clinical description that prompted the discovery of theC. difficileas the causative agent of this disease by Tedesco and colleagues (1) in 1974, was shown in...References1. TedescoBartonAlpers FRD. Clindamycin-associated colitis. Ann Intern Med. 1974;81:429-33. LinkGoogle Scholar2. Bartlett J. Introduction. In: Rolfe RD, Finegold SM, eds. Clostridium Difficile: Its Role in Intestinal Disease. San Diego: Academic Press, Inc. 1988:1-13. CrossrefGoogle Scholar3. SwartzbergMarescaRemington JRJ. Gastrointestinal side effects associated with clindamycin. Arch Intern Med. 1976;136:876-9. CrossrefMedlineGoogle Scholar4. BartlettChangGurwithGorbachOnderdonk JTMSA. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978;298:531-4. CrossrefMedlineGoogle Scholar5. PetersonOlsonShanholtzerGerding LMCD. Results of a prospective, eighteen-month clinical evaluation of culture, cytotoxin testing, and Culturette Brand (CDT) latex testing in the diagnosis of C. difficile-associated diarrhea. Diagn Microbiol and Infect Dis. 1988;10:85-91. CrossrefMedlineGoogle Scholar6. GerdingOlsonPeterson DML. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med. 1986;146:95-100. CrossrefMedlineGoogle Scholar7. LashnerTodorczukSahmHanauer BJDS. Clostridium difficile culture-positive toxin-negative diarrhea. Am J Gastroenterol 1986;81:940-3. MedlineGoogle Scholar8. TeasleyGerdingOlson DDM. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet. 1983;2:1043-6. CrossrefMedlineGoogle Scholar9. HeardO'FarrellHollandCrookBarnettTabaqchali SSDSMS. The epidemiology of Clostridium difficile with use of a typing scheme: nosocomial acquisition and cross-infection among immunocompromised patients. J Infect Dis. 1986;153:159-62. CrossrefMedlineGoogle Scholar10. MulliganPetersonKwokClabotsGerding MLRCD. Immunoblots and plasmid fingerprints compared with serotyping and polyacrylamide gel electrophoresis for typing Clostridium difficile. J Clin Microbiol. 1988;26:41-6. CrossrefMedlineGoogle Scholar11. DevlinAuFouxBradbury HWLW. Restriction endonuclease analysis of nosocomial isolates of Clostridium difficile. J Clin Microbiol. 1987;25:2168-72. CrossrefMedlineGoogle Scholar12. BaconFeketySchabertFaix ARDR. Epidemiology of Clostridium difficile colonization in newborns: results using a bacteriophage and bacteriocin typing system. J Infect Dis. 1988;158:349-54. CrossrefMedlineGoogle Scholar13. Mulligan M. Epidemiology of Clostridium difficile-induced intestinal disease. Rev Infect Dis. 1984;6(Suppl 1):S222-8. CrossrefMedlineGoogle Scholar14. ClabotsPetersonGerding CLD. Characterization of a nosocomial Clostridium difficile outbreak using plasmid profile typing and clindamycin susceptibility. J Infect Dis. 1988;158:731-6. CrossrefMedlineGoogle Scholar15. FeketyKimBrownBattsCudmoreSilva RKDDMJ. Epidemiology of antibiotic-associated colitis: isolation of Clostridium difficile from the hospital environment. Am J Med. 1981;70:906-8. CrossrefMedlineGoogle Scholar16. GerdingJohnsonOlsonWeilerHughesClabots DSMMRC. Prospective controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. Abstracts of the Eighty-Eighth Annual Meeting of American Society for Microbiology, May 8-13, 1988, Miami Beach, Florida. Abstract #L-32, American Society for Microbiology, Washington DC, 1988;416. Google Scholar17. LynchJacksonCummingsStamm PMMW. Rethinking the role of isolation practices in the prevention of nosocomial infections. Ann Intern Med. 1987;107:243-6. LinkGoogle Scholar18. BenderBennettLaughon BRB. Is Clostridium difficile endemic in chronic-care facilities? Lancet. 1986;2:11-3. CrossrefMedlineGoogle Scholar19. DelmeeVandercamAvesaniMichaux MBVJ. Epidemiology and prevention of Clostridium difficile infections in a leukemia unit. Eur J Clin Microbiol. 1987;6:623-7. CrossrefMedlineGoogle Scholar20. BoltonCulshaw RM. Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic-associated colitis due to Clostridium difficile. Gut. 1986;27:1169-72. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Veterans Administration Medical Center University of Minnesota Medical School Minneapolis, Minnesota PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByClostridium difficile infection in fever patients with gynecological malignanciesEvaluation of risk factors for a fulminant Clostridium difficile infection after cardiac surgery: a single-center, retrospective cohort studyClostridium difficile carriage in adult cystic fibrosis (CF); implications for patients with CF and the potential for transmission of nosocomial infectionAntimicrobial susceptibility of Clostridium difficile isolated from food animals on farmsRapid detection of ermB gene in Clostridium difficile by loop-mediated isothermal amplificationDetection of toxigenic Clostridium difficile in powdered infant and follow-up formulae in EgyptNovel avenues for Clostridium difficile infection drug discoveryRecent New Drug Approvals, Part 2: Drugs Undergoing Active Clinical Studies in ChildrenFidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trialFidaxomicin: The Newest Addition to the Armamentarium Against Clostridium difficile InfectionsFidaxomicin: first-in-class macrocyclic antibioticClostridium difficile InfectionPostoperative Clostridium difficile-associated diarrheaAnaerobic InfectionsClostridium difficile and the Disease It CausesClostridium difficile en el anciano: actualización epidemiológica y terapéuticaA DNA vaccine targeting the receptor-binding domain of Clostridium difficile toxin AA clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibioticsSafety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers following Single and Multiple Oral DosesClostridium difficile: Emergence of Hypervirulence and Fluoroquinolone ResistanceDiarrea asociada a Clostridium difficile en el paciente ancianoNarrative Review: The New Epidemic of Clostridium difficile–Associated Enteric DiseaseJohn G. Bartlett, MDContinuation of Antibiotics Is Associated With Failure of Metronidazole for Clostridium difficile-Associated DiarrheaSpecific risk factors for Clostridium difficile-associated diarrhea: A prospective, multicenter, case control evaluationA Large Outbreak of Clostridium difficile –Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone UseIn Vitro Activity of Ramoplanin against Clostridium difficile , Including Strains with Reduced Susceptibility to Vancomycin or with Resistance to MetronidazoleAntibiotic-Associated DiarrheaThe Role of Physical Proximity in Nosocomial DiarrheaEffectiveness of infection control program in controlling nosocomial Clostridium difficileComparison of Restriction Enzyme Analysis, Arbitrarily Primed PCR, and Protein Profile Analysis Typing for Epidemiologic Investigation of an Ongoing Clostridium difficile OutbreakGastrointestinal InfectionsTHE EMERGENCY DEPARTMENT APPROACH TO DIARRHEAMulticenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutinationComparison of arbitrarily-primed polymerase chain reaction, restriction enzyme analysis and pulsed-field gel electrophoresis for typing Clostridium difficileClostridium difficile-Associated Diarrhea and ColitisEffectiveness of Liquid Soap vs. Chlorhexidine Gluconate for the Removal of Clostridium difficile from Bare Hands and Gloved HandsEffectiveness of Liquid Soap vs. Chlorhexidine Gluconate for the Removal of Clostridium Difficile from Bare Hands and Gloved HandsManagement and control of a large outbreak of diarrhoea due to Clostridium difficileInfective DiarrhoeaInactivation of Clostridium Difficile Spores by DisinfectantsSaccharomyces boulardii'. A Review of an Innovative Biotherapeutic AgentProspective study of oral teicoplanin versus oral vancomycin for therapy of pseudomembranous colitis and Clostridium difficile-associated diarrheaAntibiotic-associated colitis and cystic fibrosisTetracyclines, Chloramphenicol, Erythromycin, Clindamycin, and MetronidazoleThe child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategiesControl of nosocomial transmission of Clostridium difficile based on sporadic case surveillanceRisk Factors for the Development of Clostridium difficile -Associated Diarrhea During a Hospital OutbreakRisk Factors for the Development of Clostridium difficile-Associated Diarrhea during a Hospital OutbreakLower Intestinal Bleeding in the ElderlyRole of candida in pathogenesis of antibiotic-associated diarrhoea in elderly inpatientsRisk Factors for Clostridium difficile Cytotoxin-Positive Diarrhea after Control for Horizontal TransmissionThe Office Evaluation of Infectious DiarrheaNosocomial Escherichia coli 0157:H7 diarrheaClostridium difficile -Associated Disease in Long-Term Care FacilitiesInfectious Causes of Diarrhea in the Differential Diagnosis of Inflammatory Bowel DiseaseEvolution of the Concept of Proctosigmoiditis: Clinical ObservationProspective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infectionsIdentification of Clostridium difficile in stool specimens by culture-enhanced gas-liquid chromatographyRecent Developments in the Understanding of the Pathogenesis and Treatment of Anaerobic Infections 15 February 1989Volume 110, Issue 4Page: 255-257KeywordsC difficile colitisClostridium difficileClostridium infectionsColitisDiarrheaDysenteryEnterocolitisMegacolon Issue Published: 15 February 1989 PDF DownloadLoading ...
Dale N. Gerding (Wed,) studied this question.